Wound Sampling - MolecuLight US

Research Category:Wound Sampling, Chronic Wounds

Use of fluorescence imaging to optimize location of tissue sampling in hard-to-heal wounds

Front. Cell. Infect. Microbiol., 12 January 2023, Vol. 12 - 2022

Download Publication

Research Category:Wound Sampling, Chronic Wounds

The safety of punch biopsies on hard-to-heal wounds: a large multicentre clinical trial

Journal of Wound Care, Feb. 2020, Vol. 29, Issue 2

Download Publication

Research Category:Wound Sampling, Chronic Wounds

Point-of-care fluorescence imaging predicts the presence of pathogenic bacteria in wounds: a clinical study

Journal of Wound Care, 2017, 26(8), 452-460. doi: 10.12968/jowc.2017.26.8.452.

Download Publication

Research Category:Wound Sampling, Chronic Wounds

Improved detection of clinically relevant wound bacteria using autofluorescence image-guided sampling in diabetic foot ulcers

International Wound Journal, 2017, 14(5), 833-841. doi: 10.1111/iwj.12717.

Download Publication

Find out how to make a difference in wound care

MolecuLight Headquarters

425 University Avenue
Suite 700
Toronto, ON M5G 1T6
Canada

US Address
MolecuLight Corp.
2403 Sidney Street,
Suite 209
Pittsburgh, PA 15203

T. 1-877-818-4360
North American Toll Free:
1-877-818-4360
F.+1 647-362-4730
E: info@moleculight.com

MolecuLight is SOC ll^®
Type l Accredited:

MolecuLight awarded
Premier’s Technology
Breakthrough Designation

MolecuLight i:X
is designated as a:

MolecuLight included
in ISWCAP Consensus
Guidelines:

MolecuLight is a proud
corporate member of:

Global

USA

©2024
The MolecuLight® i:X and MolecuLightDX™ Imaging Devices are approved by Health Canada for sale in Canada and has CE marking for sale in the European Union.
The MolecuLight™ i:X and DX Imaging Devices have received FDA clearance.